Eli Lilly - 47 Year Stock Price History | LLY

Historical daily share price chart and data for Eli Lilly since 1972 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Eli Lilly as of March 22, 2019 is 128.30.
Eli Lilly Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 120.5455 114.2696 128.8400 110.7186 128.3000 11.46%
2018 92.1864 82.1696 118.0096 72.0100 115.1052 40.45%
2017 78.7983 70.5449 85.2845 70.5260 81.9561 17.83%
2016 71.3311 76.3224 78.0370 62.3840 69.5520 -10.37%
2015 71.7311 62.8592 82.3563 61.8175 77.6026 25.37%
2014 54.5272 44.0572 65.3445 44.0572 61.8992 39.75%
2013 44.9286 41.4614 49.2955 40.9851 44.2917 7.24%
2012 35.7407 33.4290 44.5988 31.1701 41.3023 24.27%
2011 28.7351 26.5280 33.3890 25.8514 33.2371 25.15%
2010 25.9521 25.6865 28.4489 23.7885 26.5583 3.71%
2009 23.9627 27.5173 27.5173 18.8806 25.6076 -6.25%
2008 30.1531 34.1298 37.1368 20.2870 27.3138 -21.23%
2007 35.5038 32.9147 38.4482 31.8826 34.6753 5.65%
2006 34.2044 35.0764 36.4249 31.2921 32.8202 -5.16%
2005 33.1859 33.4580 36.3823 30.2056 34.6055 2.52%
2004 38.7328 41.4703 44.6035 29.8119 33.7554 -17.55%
2003 36.6075 37.7459 43.0129 30.7742 40.9405 13.14%
2002 36.5884 43.8682 45.2757 27.1470 36.1846 -17.56%
2001 44.2601 50.4377 50.4377 40.1540 43.8905 -14.44%
2000 43.1211 35.6342 59.4280 29.7476 51.2976 41.92%
1999 40.8630 46.1684 52.4476 33.3265 36.1451 -24.25%
1998 38.1311 36.5986 48.7882 31.0171 47.7145 29.08%
1997 27.7085 18.9086 37.1295 18.9086 36.9649 94.15%
1996 16.2870 14.1323 20.6691 12.6318 19.0391 32.64%
1995 10.0960 8.0464 14.4181 7.7541 14.3543 77.39%
1994 6.8134 7.0000 8.0920 5.6601 8.0920 15.60%
1993 5.9525 6.9018 7.1461 5.0869 7.0000 2.47%
1992 7.5672 9.2453 9.4893 6.5619 6.8310 -24.89%
1991 8.3494 7.7595 9.2453 7.3595 9.0950 16.41%
1990 7.5587 7.1316 9.4660 6.1986 7.8128 9.95%
1989 5.8379 4.3344 7.1056 4.3344 7.1056 64.17%
1988 4.1437 3.9229 4.6077 3.4925 4.3283 12.81%
1987 4.3026 3.6283 5.1124 3.0297 3.8369 5.75%
1986 3.4110 2.6815 4.0315 2.4861 3.6283 33.18%
1985 2.0723 1.5852 2.7243 1.5820 2.7243 68.94%
1984 1.4877 1.4538 1.6341 1.3194 1.6126 14.03%
1983 1.5307 1.4020 1.6707 1.3866 1.4142 0.66%
1982 1.3904 1.3622 1.5882 1.1361 1.4049 2.67%
1981 1.4251 1.5393 1.6676 1.1391 1.3683 -11.97%
1980 1.3021 1.4171 1.5544 1.1269 1.5544 6.71%
1979 1.3513 1.1728 1.5515 1.1635 1.4567 24.86%
1978 1.0994 0.9224 1.3133 0.8979 1.1667 26.06%
1977 0.9481 1.1513 1.1513 0.8034 0.9255 -20.46%
1976 1.2602 1.2490 1.4660 1.0658 1.1635 -7.75%
1975 1.6066 1.6400 1.9332 1.2432 1.2612 -24.09%
1974 1.6944 1.7929 2.0065 1.3744 1.6615 -8.11%
1973 1.9940 1.9332 2.2386 1.7133 1.8081 -7.06%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $132.844B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $367.316B 16.74
Pfizer (PFE) United States $249.127B 13.95
Merck (MRK) United States $221.869B 18.96
Novartis AG (NVS) Switzerland $215.800B 18.35
Novo Nordisk (NVO) Denmark $123.936B 20.05
AbbVie (ABBV) United States $117.653B 10.08
Sanofi (SNY) France $111.008B 13.70
AstraZeneca (AZN) United Kingdom $107.876B 12.31
GlaxoSmithKline (GSK) United Kingdom $102.325B 13.44
Bristol-Myers Squibb (BMY) United States $78.630B 12.10